PARD - Poniard Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
As of Date: 7/8/2020
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 2.45
52-Week Change 3150.00%
S&P500 52-Week Change 35.03%
52 Week High 30.1000
52 Week Low 30.0100
50-Day Moving Average 30.0700
200-Day Moving Average 30.0553

Share Statistics

Avg Vol (3 month) 3906
Avg Vol (10 day) 32k
Shares Outstanding 51.5M
Float N/A
% Held by Insiders 10.00%
% Held by Institutions 10.00%
Shares Short (Nov 29, 2011) 447.72k
Short Ratio (Nov 29, 2011) 42.56
Short % of Float (Nov 29, 2011) 44.15%
Short % of Shares Outstanding (Nov 29, 2011) 43.18%
Shares Short (prior month Oct 13, 2011) 43.73k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:40
Last Split Date 3Nov 22, 2011

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2010
Most Recent Quarter (mrq)Sep 29, 2011


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-46.03%
Return on Equity (ttm)-210.37%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -13.04M
Net Income Avi to Common (ttm)-16.23M
Diluted EPS (ttm)-3.7910
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.98M
Total Cash Per Share (mrq)1.32
Total Debt (mrq)1.64M
Total Debt/Equity (mrq)52.62
Current Ratio (mrq)0.76
Book Value Per Share (mrq)2.08

Cash Flow Statement

Operating Cash Flow (ttm)-10.46M
Levered Free Cash Flow (ttm)-4.53M